Zorgkeuzelab
Zorgkeuzelab is a Delft-based Dutch digital health company that develops and implements over 25 evidence-based patient decision aids across oncology, cardiology, neurology, and urology, serving 52 Dutch hospitals and 200+ clinical teams via a subscription and implementation-support model.
- Company typePrivate
- Founded2013
- HeadquartersDelft, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Zorgkeuzelab does
Zorgkeuzelab (ZorgKeuzeLab BV) is a Dutch digital health company founded in 2013 by service designers Regina The and Klemens Karssen, headquartered in Delft. The company develops evidence-based patient decision aids ("keuzehulpen") that support shared decision-making between patients and healthcare providers across a growing portfolio of over 25 conditions spanning oncology (breast, prostate, lung, colorectal, kidney, bladder, pancreatic), cardiology (heart valve, ICD), neurology (Parkinson's, stroke), urology (BPH, incontinence), respiratory (asthma), and other specialties. Each decision aid is co-developed with relevant scientific medical societies and patient organizations, and a specialized Patient-Like-Me module for stage IV lung cancer surfaces anonymized outcome data stratified by ECOG score and PD-L1 expression to personalize treatment choice.
The underlying platform combines online interactive decision aids accessible to patients at home with companion printable handouts used in consultations, plus a team reporting system that delivers monthly and quarterly implementation metrics. Implementation is sold and delivered as a 3-9 month structured hospital engagement including team training, on-site kickoff, and ongoing coaching from a dedicated implementation coordinator.
The business operates a subscription-based model tied to hospital implementations, bundled with implementation services and continuous content updates to reflect current clinical guidelines. Pricing is not publicly disclosed; a free trial package is offered to hospitals before full subscription commitment. Zorgkeuzelab serves 52 Dutch hospitals and 200+ clinical teams, with collective case-study customers including Reinier de Graaf Gasthuis, Gelre Ziekenhuizen, Jeroen Bosch Ziekenhuis, OLVG, Erasmus MC, and Santeon hospital group. Since December 2023 the company has been a subsidiary of Performation, a larger Dutch healthcare services organization, marking its transition from independent startup to scaling phase; in February 2026 co-founder Klemens Karssen departed after 13 years, with Regina The continuing as General Director. The company has raised no institutional venture funding; non-dilutive support has included a KWF grant for nationwide lung-cancer decision aid rollout.
Zorgkeuzelab firmographics
Firmographics- Name
- Zorgkeuzelab
- Legal name
- ZorgKeuzeLab BV
- Website
- https://zorgkeuzelab.nl
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Zorgkeuzelab is a Delft-based Dutch digital health company that develops and implements over 25 evidence-based patient decision aids across oncology, cardiology, neurology, and urology, serving 52 Dutch hospitals and 200+ clinical teams via a subscription and implementation-support model.
- Ownership category
- akta.pro rank
Zorgkeuzelab industry classification
Industry- Product category
- Healthcare Decision Support Software
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Order Sets, Care Plans & Clinical Pathways (CPOE-integrated) (HLACAGAC)
- akta.pro secondary industry
- Patient Intake, Digital Registration & eForms (HLACAEAF)
Keywords
Where Zorgkeuzelab is headquartered
LocationHeadquarters
- HQ city
- Delft
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Zorgkeuzelab business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Healthcare Decision Aid Subscription: ZorgKeuzeLab operates on a cost-covering development model. They develop each decision aid cost-effectively and for nationwide use. The subscription model includes personal guidance during implementation, training materials, handout blocks, online access, monthly motivational reports, quarterly reports, and ongoing support to keep decision aids up-to-date with current medical guidelines.
- Hospital Implementation Services: Implementation support services including team training, on-site kick-off training, personal coaching from implementation coordinator Annette, and ongoing support for teams and patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | One time | Trial Package (Proefpakket) |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Zorgkeuzelab product offering
Product offeringCore offering
ZorgKeuzeLab develops and implements evidence-based digital patient decision aids (keuzehulpen) that help patients understand their treatment options, weigh pros and cons, and prepare for consultations with healthcare providers. The portfolio covers more than 25 decision aids across oncology, cardiology, neurology, urology and other conditions, with accompanying implementation support including team training, personal coaching, monthly/quarterly reporting, and ongoing content updates.
Product overview
ZorgKeuzeLab is a digital health platform that develops and implements evidence-based decision aids (keuzehulpen) to support shared decision-making between patients and healthcare providers. The portfolio includes over 25 active decision aids across multiple medical specialties including oncology (breast cancer, prostate cancer, colorectal cancer, lung cancer, kidney cancer, ovarian cancer, pancreatic cancer), cardiology (heart valve, ICD), neurology (stroke, Parkinson's), urology (BPH, overactive bladder), respiratory (asthma), and other conditions. The company also maintains a pipeline of decision aids in development for burns, high-risk breast cancer, and metastatic bladder cancer. Implementation support services include team training, monthly reporting, and ongoing support, with deployment across 52 hospitals and 200+ teams in the Netherlands.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 88% patient satisfaction rate reported for lung cancer decision aid users
- +2 more outcomes
Companies that use Zorgkeuzelab
Customer profileNamed customers10 records
Segments1 record
Ideal customer profiles2 records
Zorgkeuzelab technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Zorgkeuzelab partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- PerformationcoreZorgKeuzeLab joined Performation in December 2023, entering an upscaling phase. Performation is a large, experienced healthcare organization that enables ZorgKeuzeLab to accelerate development and implementation of decision aids with professional structures and support.
- YES!DelftminorZorgKeuzeLab participated in the LaunchLab program at YES!Delft, a startup incubator, where founders Regina The and Klemens Karssen developed their initial business plan and presentation.
- Scientific Medical SocietiescoreEach decision aid is developed in collaboration with relevant medical societies and expert clinicians from leading Dutch hospitals, ensuring scientific validity and clinical relevance.
- Patient OrganizationscorePatient associations are actively involved in developing decision aids, representing the patient perspective and ensuring tools meet actual patient needs for information and support.
- SanteoncoreSanteon collaborated with ZorgKeuzeLab on development and implementation of the lung cancer decision aid. Jointly developed the Patients-Like-Me module for stage IV lung cancer patients with KWF funding.
- Longkanker NederlandcorePatient organization partner in the development of the lung cancer decision aid, representing the voice of lung cancer patients.
- NivelminorProf. dr. Sandra van Dulmen from Nivel serves on the Advisory Board, providing expertise in eHealth and patient participation.
- University of TwenteminorProf. dr. S. Siesling from University of Twente serves on the Advisory Board with expertise in clinical epidemiology.
- Pink RibbonminorPink Ribbon co-funded the implementation research for the breast cancer decision aid developed with MUMC+.
- OPTIONS Study (KWF funded)coreKWF-funded research project developing decision aids for women with elevated breast cancer risk, implemented across all academic hospitals and Antoni van Leeuwenhoek.
- Stichting Erfelijke Kanker NederlandcorePatient organization partner in the development of the decision aid for women with hereditary breast cancer risk.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Zorgkeuzelab competitors and assessment
Company assessmentDirect peers
- Healthwise: US-based nonprofit that develops evidence-based patient decision aids and health content deployed across major US health systems. Most direct international comparator to ZorgKeuzeLab's evidence-based, society-co-developed decision aid model serving hospitals at scale.
- WiserCare: Patient decision support platform that delivers personalized treatment choice tools to patients in US health systems. Directly comparable product offering (interactive shared decision-making tools) and customer base (hospitals and specialty practices).
- Option Grid (EBSCO Health): Evidence-based patient decision aids (originally Option Grid, now part of EBSCO Health/DynaMed) covering multiple treatment options across conditions. Competes in the same SDM/decision aid category with similar evidence-based development methodology.
Broad incumbents
- Shared Decision Making aids via Mayo Clinic / Mayo Clinic Shared Decision Making National Resource Center: Mayo Clinic's SDM program develops decision aids and trains clinicians nationally. Comparable in clinical credibility and content development methodology, though embedded within a much larger academic medical institution rather than an independent vendor.
- PatientPoint: Large US patient engagement platform delivering education and decision support content in physician offices and health systems. Adjacent in patient engagement category with overlapping hospital customer base and content-driven approach.
- Wolters Kluwer (UpToDate Decision Aids): Global health information provider whose UpToDate and clinical decision tools are used in Dutch and European hospitals. Broad incumbent with overlapping clinical decision support content and direct hospital relationships that compete for SDM mindshare.
- Elsevier (ClinicalPath / patient engagement): Major medical publisher and clinical decision support vendor with patient-facing tools and care pathway products. Comparable as broad incumbent with content depth and hospital distribution that could expand into SDM space.
Others
- Performation: Parent company of ZorgKeuzeLab since December 2023; Dutch healthcare consultancy focused on Value Based Healthcare. Parent/owner relationship, but also comparable as Dutch healthcare process innovation consultant supporting hospital quality improvement.
- ChipSoft (HiX EHR): Dominant Dutch EHR vendor (HiX) used by most Dutch hospitals. Indirect competitor/potential channel partner, as EHR-embedded SDM modules could compete with or integrate ZorgKeuzeLab's standalone platform.
Emerging players
- Infermedica: AI-driven symptom checker and digital health triage platform used by insurers and health systems across Europe. Adjacent emerging player in patient-facing clinical decision tools with comparable enterprise health customer model and European footprint.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Zorgkeuzelab social profiles
Digital presenceZorgkeuzelab compliance and trust
Trust signalCompliance5 records
Zorgkeuzelab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zorgkeuzelab leadership team
Management profileNumber of profiles
Profiles8 records
Zorgkeuzelab funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zorgkeuzelab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zorgkeuzelab
What does Zorgkeuzelab do?
ZorgKeuzeLab develops and implements evidence-based digital patient decision aids (keuzehulpen) that help patients understand their treatment options, weigh pros and cons, and prepare for consultations with healthcare providers. The portfolio covers more than 25 decision aids across oncology, cardiology, neurology, urology and other conditions, with accompanying implementation support including team training, personal coaching, monthly/quarterly reporting, and ongoing content updates.
Is Zorgkeuzelab a public or private company?
Zorgkeuzelab is a private company. It is classified as corporate owned and is currently operating.
When was Zorgkeuzelab founded?
Zorgkeuzelab was founded in 2013. It employs 1 to 10 people.
Where is Zorgkeuzelab based?
Zorgkeuzelab is headquartered in Delft, Netherlands, in the Europe region.
How does Zorgkeuzelab make money?
Two revenue lines are on record. Healthcare Decision Aid Subscription is the primary driver. The others are hospital Implementation Services.
Who are Zorgkeuzelab's main competitors?
Direct peers on record are Healthwise, WiserCare and Option Grid (EBSCO Health). Broad incumbents are Shared Decision Making aids via Mayo Clinic / Mayo Clinic Shared Decision Making National Resource Center, PatientPoint, Wolters Kluwer (UpToDate Decision Aids) and Elsevier (ClinicalPath / patient engagement). Others are Performation and ChipSoft (HiX EHR). Infermedica is listed as an emerging player.
Does Zorgkeuzelab have an API?
No public API is recorded for Zorgkeuzelab.
What industry is Zorgkeuzelab in?
Zorgkeuzelab's product category is Healthcare Decision Support Software. Its primary akta.pro industry code is HLACAGAC, Order Sets, Care Plans & Clinical Pathways (CPOE-integrated), with a secondary code of HLACAEAF, Patient Intake, Digital Registration & eForms. Its NAICS code is 54169 and its SIC code is 8742.